| Biofilm Formation by the Fungal PathogenCandida albicans: Development, Architecture, and Drug Resistance J Chandra, DM Kuhn, PK Mukherjee, LL Hoyer, T McCormick, ... Journal of bacteriology 183 (18), 5385-5394, 2001 | 2097 | 2001 |
| Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance MA Ghannoum, LB Rice Clinical microbiology reviews 12 (4), 501-517, 1999 | 2042 | 1999 |
| Potential role of phospholipases in virulence and fungal pathogenesis MA Ghannoum Clinical microbiology reviews 13 (1), 122-143, 2000 | 1131 | 2000 |
| Characterization of the oral fungal microbiome (mycobiome) in healthy individuals MA Ghannoum, RJ Jurevic, PK Mukherjee, F Cui, M Sikaroodi, A Naqvi, ... PLoS pathogens 6 (1), e1000713, 2010 | 1078 | 2010 |
| Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole … JH Rex, MA Pfaller, JN Galgiani, MS Bartlett, A Espinel-Ingroff, ... Clinical Infectious Diseases 24 (2), 235-247, 1997 | 995 | 1997 |
| Antifungal Susceptibility of Candida Biofilms: Unique Efficacy of Amphotericin B Lipid Formulations and Echinocandins DM Kuhn, T George, J Chandra, PK Mukherjee, MA Ghannoum Antimicrobial agents and chemotherapy 46 (6), 1773-1780, 2002 | 926 | 2002 |
| Antifungal resistance of candidal biofilms formed on denture acrylic in vitro J Chandra, PK Mukherjee, SD Leidich, FF Faddoul, LL Hoyer, LJ Douglas, ... Journal of dental research 80 (3), 903-908, 2001 | 747 | 2001 |
| A large-scale North American study of fungal isolates from nails: the frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns MA Ghannoum, RA Hajjeh, R Scher, N Konnikov, AK Gupta, ... Journal of the American Academy of Dermatology 43 (4), 641-648, 2000 | 654 | 2000 |
| Comparison of Biofilms Formed by Candidaalbicans and Candidaparapsilosis on Bioprosthetic Surfaces DM Kuhn, J Chandra, PK Mukherjee, MA Ghannoum Infection and immunity 70 (2), 878-888, 2002 | 642 | 2002 |
| Antifungal susceptibility testing: practical aspects and current challenges JH Rex, MA Pfaller, TJ Walsh, V Chaturvedi, A Espinel-Ingroff, ... Clinical microbiology reviews 14 (4), 643-658, 2001 | 627 | 2001 |
| Mechanism of Fluconazole Resistance in Candida albicans Biofilms: Phase-Specific Role of Efflux Pumps and Membrane Sterols PK Mukherjee, J Chandra, DM Kuhn, MA Ghannoum Infection and immunity 71 (8), 4333-4340, 2003 | 609 | 2003 |
| Indoor Mold, Toxigenic Fungi, and Stachybotrys chartarum: Infectious Disease Perspective DM Kuhn, MA Ghannoum Clinical microbiology reviews 16 (1), 144-172, 2003 | 503 | 2003 |
| Evidence implicating phospholipase as a virulence factor of Candida albicans AS Ibrahim, F Mirbod, SG Filler, Y Banno, GT Cole, Y Kitajima, ... Infection and immunity 63 (5), 1993-1998, 1995 | 471 | 1995 |
| Extracellular phospholipase activity is a virulence factor for Cryptococcus neoformans GM Cox, HC McDade, SCA Chen, SC Tucker, M Gottfredsson, LC Wright, ... Molecular microbiology 39 (1), 166-175, 2001 | 460 | 2001 |
| Zygomycosis: the re-emerging fungal infection M Chayakulkeeree, MA Ghannoum, JR Perfect European Journal of Clinical Microbiology and Infectious Diseases 25, 215-229, 2006 | 415 | 2006 |
| Uses and Limitations of the XTT Assay in Studies of Candida Growth and Metabolism DM Kuhn, M Balkis, J Chandra, PK Mukherjee, MA Ghannoum Journal of clinical microbiology 41 (1), 506-508, 2003 | 406 | 2003 |
| The gut microbiome as a major regulator of the gut-skin axis I Salem, A Ramser, N Isham, MA Ghannoum Frontiers in microbiology, 1459, 2018 | 401 | 2018 |
| Combination treatment of invasive fungal infections PK Mukherjee, DJ Sheehan, CA Hitchcock, MA Ghannoum Clinical microbiology reviews 18 (1), 163-194, 2005 | 376 | 2005 |
| Epidemiologic surveillance of cutaneous fungal infection in the United States from 1999 to 2002 KW Foster, MA Ghannoum, BE Elewski Journal of the American Academy of Dermatology 50 (5), 748-752, 2004 | 371 | 2004 |
| Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia … JH Rex, MA Pfaller, AL Barry, PW Nelson, CD Webb Antimicrobial Agents and Chemotherapy 39 (1), 40-44, 1995 | 352 | 1995 |
